Patents by Inventor Juan Ramon Gonzalez

Juan Ramon Gonzalez has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210330932
    Abstract: A catheter including a tubular catheter body defining a distal portion, a distal end and a lumen that extends to the distal end, a radiopaque marker carried within the lumen, and a non-metal tip that is bonded to distal end of the catheter body.
    Type: Application
    Filed: July 3, 2021
    Publication date: October 28, 2021
    Inventors: Juan Ramon Gonzalez, Sam William Bowman, Rudolph A. Montalvo
  • Patent number: 11123516
    Abstract: A catheter including a tubular catheter body defining a distal portion, a distal end and a lumen that extends to the distal end, a radiopaque marker carried within the lumen, and a non-metal tip that is bonded to distal end of the catheter body.
    Type: Grant
    Filed: July 20, 2018
    Date of Patent: September 21, 2021
    Assignee: Medtronic Minimed, Inc.
    Inventors: Juan Ramon Gonzalez, Sam William Bowman, Rudolph A. Montalvo
  • Publication number: 20190022352
    Abstract: A catheter including a tubular catheter body defining a distal portion, a distal end and a lumen that extends to the distal end, a radiopaque marker carried within the lumen, and a non-metal tip that is bonded to distal end of the catheter body.
    Type: Application
    Filed: July 20, 2018
    Publication date: January 24, 2019
    Inventors: Juan Ramon Gonzalez, Sam William Bowman, IV, Rudolph A. Montalvo
  • Publication number: 20140315737
    Abstract: The present invention relates to a group of epilepsy biomarkers comprising (i) SNP rs2740574; (ii) SNP rs1799735; (iii) SNP rs1695; (iv) SNP rs6280; and the locus of the human glutathione S-transferase theta-1 (GSTT1) gene. The invention particularly relates to this group of biomarkers as marker for protection against drug-resistant epilepsy. The group of biomarkers may additionally comprise at least one clinical marker selected from the group comprising (i) a focal seizure with secondary generalization; (ii) age at confirmed diagnosis of epilepsy; (iii) atrophy of hippocampus or medial temporal sclerosis; and (iv) the presence of a brain tumor.
    Type: Application
    Filed: April 18, 2014
    Publication date: October 23, 2014
    Inventors: CARLOS CARA TERRIBAS, JUAN RAMON GONZALEZ RUIZ, ANTONIO MARTINEZ MARTINEZ, ESTIBALIZ OLANO MARTIN, LAUREANO SIMON BUELA
  • Publication number: 20120202680
    Abstract: A process for preparing a zeolite-based monolith including dry-mixing zeolite particles and a temporary binder until homogenization; adding silica and water dispersion; wet-kneading and high-shear mixing until obtaining a homogenous pulp; extrusion-molding the pulp resulting from the previous step; controlled drying of the mold obtained; and oxidizing at a high temperature to obtain the monolith.
    Type: Application
    Filed: March 26, 2010
    Publication date: August 9, 2012
    Applicant: UNIVERSIDAD DEL PAIS VASCO-EUSKAL HERRIKO UNIBERTSITATEA
    Inventors: Asier Aranzabal Maiztegui, Deiene Iturbe Vallejo, María del Pilar González Marcos, José Antonio González Marcos, Juan Ramón González Velasco, Manuel Romero Sáez